Table 2 Clinicopathological characteristics of patients stratified by pre-CRT LCR
Characteristic | LCR low (n = 24) | LCR high (n = 24) | P value |
|---|---|---|---|
Age (years) | 66 ± 13 | 65 ± 10 | 0.45 |
Gender (male/female) | 16/8 | 16/8 | 1.00 |
WBC (/μL) | 7266 | 6299 | 0.13 |
TLC (/μL) | 1451 ± 640 | 1803 ± 502 | 0.07 |
Alb (mg/dL) | 3.8 ± 0.5 | 3.9 ± 0.5 | 0.58 |
CRP (mg/dL) | 1.23 ± 2.47 | 0.07 ± 0.02 | < 0.05 |
Tumor characteristic | |||
 Differentiation (tub1/tub2/other) | 13/7/4 | 16/4/4 | 0.53 |
 CEA (</≥ 5 ng/mL) | 16/8 | 18/6 | 1.00 |
 CA19-9 (</≥ 37 IU/mL) | 20/4 | 20/4 | 0.09 |
 Pre-CRT stage (I/II/III) | 1/3/16 | 2/8/12 | 0.17 |
Treatment | |||
 Chemotherapy (S-1/UFT/5FU) | 13/7/4 | 16/4/4 | 0.57 |
 Surgery (LAR/ISR/APR/local) | 7/4/13/0 | 11/6/5/2 | 0.07 |
Pathological response (grade 2/> 2) | 17/7 | 15/9 | 0.53 |